Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

NATURECEUTICALS SDN. BHD.

Home Clinical Trial Sponsors and OrganizationsNATURECEUTICALS SDN. BHD.

NATURECEUTICALS SDN. BHD.

ACTIVE

A-1-1 & A-1-2, Sungai Petani, Kedah, MalaysiaPrivate

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

18

6 active

Approvals

3

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

9

50.0%

Phase 2/3

3

16.7%

Phase 1

2

11.1%

Phase 1/2

1

5.6%

Phase 2

1

5.6%

Trial Status Distribution

Active, not recruiting

1

5.6%

Completed

5

27.8%

Not yet recruiting

5

27.8%

Recruiting

5

27.8%

Unknown

2

11.1%

Clinical Trials

Trials sponsored by this organization (18)

to check the Effect and Safety of Nuvastatic™ in Reducing Cancer Related Fatigue in Colon Cancer Patients

Not yet recruiting

Oct 2025180 participants

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.

Oct 2025250 participants

Nuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast Cancer

Oct 2025250 participants

Evaluation of NuvastaticTM in Reducing Cancer-Related Fatigue in Colon Cancer Patients Undergoing First-Line Chemotherapy

Aug 2025180 participants

To check the effect and Safety of Nuvastatic in Reducing Cancer Related Fatigue in Breast Cancer Patients who are taking Chemotherapy

Not yet recruiting

Jun 2025180 participants

A Study to Evaluate the Efficacy and Safety of Orally Administered Extract of Orthosiphon Stamineus (NuvastaticTM-C5OSEW5050ESA) in Patient With Breast Cancer Undergoing Chemotherapy

Jun 2025180 participants

To see the safety and effectiveness NuvastaticÂ® 300 mg in reducing chemotherapy induced fatigue in patients with metastatic triple negative breast cancer receiving standard chemotherapy

Nov 2024250 participants

To see the safety and effectiveness of NuvastaticÂ® 300mg capsule in fatigue who are receiving chemotherapy with patients suffering with colorectal cancer

Nov 2024200 participants

Page 1 of 3

Approvals

Approvals by Agency

NPRA

National Pharmaceutical Regulatory Agency

3

Approvals

Recent Approvals

Nuvastatic Effervescing Powder

Canssu-5 Effervescing Powder

Nuvastatic 500 Effervescing Powder

News

No news articles found

On this page

Overview
Clinical Trials18
Approvals3
News

Back to Organizations